Case Studies on Corporations & Global Health Governance, edited by Nora Kenworthy, Ross MacKenzie and Kelley Lee, presents interdisciplinary case studies on how corporations influence global health governance and how they could be held more accountable. The empirical studies examine several industries across high, low and middle income countries and explore the impact of corporations and their allies on the governance processes that shape population health.
“Exxon and its allies have dismissed comparisons to Big Tobacco as baseless”, writes Smoke and Fumes, a project of the Center for International Environmental Law. “Our research in more than 14 million documents of the Tobacco Industry Archives reveals compelling evidence that the relationship between these two industries is neither coincidental nor casual. Beyond a doubt, the oil companies have benefitted from the tobacco playbook in their fight against climate science. But the question arises, where did the tobacco companies get their playbook in the first place?” Read more.
In his new book, Moral Jeopardy: Risks of Accepting Money from the Alcohol, Tobacco and Gambling Industries (Cambridge University Press, 2016), Peter Adams examines the ethical issues that arise when people and organizations accept money from tobacco, alcohol and gambling corporations. Adams is professor and deputy head of the School of Population Health at the University of Auckland in New Zealand and an associate director of its Centre for Addiction Research. Corporations and Health Watch’s Nick Freudenberg conducted this e-mail interview of Adams. Continue reading Moral Jeopardy: What are the risks of accepting money from the alcohol, tobacco and gambling industries?
Philip Morris International just lost a six-year battle to block Uruguay’s strong cigarette warning labels, which cover 80 percent of the front and back of cigarette packs, including graphic photos of the damages of smoking, write Eric Crosbie and Stanton Glanz in The Conversation. Continue reading Philip Morris gets its ash kicked in Uruguay; where will it next blow smoke?
The adverse health and equity impacts of transnational corporations’ (TNCs) practices have become central public health concerns as TNCs increasingly dominate global trade and investment and shape national economies. Despite this, methodologies have been lacking with which to study the health equity impacts of individual corporations and thus to inform actions to mitigate or reverse negative and increase positive impacts. A new report in Globalization and Health describes a framework designed to conduct corporate health impact assessment (CHIA), that was developed at a meeting held at the Rockefeller Foundation Bellagio Center in May 2015.
Cigarette packs have long served as portable advertising for tobacco companies, with smokers conveniently disseminating branding and imagery wherever they go, writes Vox Science and Health. Packaging has also long been a central target for health advocates in the global effort to get more people off deadly tobacco products. Last week, the World Health Organization called on countries everywhere to step up the war on tobacco advertising and promotion by introducing plain, or standardized, packaging of tobacco products. Notably, the United States isn’t even close to getting plain packaging on cigarettes anytime soon.
The Framework Convention on Tobacco Control (FCTC) stands as a landmark approach to addressing a global health problem. It represents the first time the World Health Organization (WHO) used its constitutional right to negotiate an international law and the first time the Member States of WHO agreed to a collective response to chronic, noncommunicable diseases. This paper draws lessons from the FCTC’s first decade in force and explores what aspects of the FCTC experience can inform future efforts to address other disease epidemics driven by corporate activity, such as alcohol and food. . doi:10.2188/jea.JE20160080